Laura Campbell
Chief Medical Officer
,
Orchard Therapeutics
Laura is an accomplished biopharma executive with unique global experience that spans a broad range of functions, therapeutic areas and who carries deep experience of gene therapies, from bench to bedside.
In her role as chief medical officer at Orchard Therapeutics, Laura leads a skilled team of professionals in clinical development, medical affairs, diagnostics, newborn screening, and patient advocacy. She drives Orchard’s progress in early- and late-stage clinical development of the company’s next-in-line gene therapies.
Prior to her appointment to CMO, Laura most recently served as vice president of clinical development, where she led the clinical sciences, , pharmacovigilance and bioanalytical assays departments at the company.
Sessions
-
Panel Discussion: How Do We Design, Execute and Adapt Clinical Trials for One-Time or Personalised Advanced Therapies?28-Jan-2026Advanced Therapies Stage